TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Shon Lowe, 52, received a mild cognitive impairment diagnosis in November 2025 after noticing memory changes and pressing for further evaluation. In an interview with Being Patient, she said caring for her mother, who had younger-onset Alzheimer’s, helped her recognize changes she felt should be investigated. The report does not establish that Lowe has Alzheimer’s disease.
Shon Lowe, 52, received a diagnosis of mild cognitive impairment (MCI) in November 2025 after seeking answers about memory changes she said reminded her of her mother’s younger-onset Alzheimer’s. In an interview published by Being Patient, Lowe described pushing for a neurology referral after a primary care provider attributed her concerns to menopause; her account underscores how her years as a caregiver informed her own diagnostic journey.
Lowe told Being Patient that she noticed forgetfulness and difficulty recalling passwords, began using Post-it notes, and sometimes put items in the wrong place, including placing something meant for the refrigerator in a cabinet. She said her youngest daughter also urged her to get checked. Lowe described sleep deprivation as another concern, but the interview does not establish what caused her symptoms.
According to Lowe, a primary care clinician initially linked her concerns mostly to menopause. She said she believed that explanation did not account for what she was experiencing and asked for a referral to a neurologist. While waiting about three months for the appointment, she arranged genetic testing through her workplace benefits and reported that the result showed one copy of the APOE4 genetic variant.
Lowe said she brought information about her symptoms and test results to the specialist visit, determined not to have her concerns dismissed. The article reports that she was diagnosed with MCI in November 2025. It does not say that the diagnosis is Alzheimer’s disease, and a reported APOE4 result does not by itself establish that someone has the disease.
How Caregiving Shaped Her Self-Advocacy
Lowe’s account shows how firsthand caregiving experience influenced the way she interpreted changes in her own memory and sought further assessment. She said her mother’s experience made some of the signs feel familiar, prompting her to keep asking for evaluation even after her concerns were initially attributed to menopause.
The report also describes a practical challenge for people seeking assessment: symptoms can have multiple possible explanations, and delays in specialist appointments can leave patients waiting for answers. Lowe’s experience is an individual account, not evidence that similar symptoms have the same cause in other people. Her story may help readers understand why documenting changes and communicating concerns to a qualified clinician can matter, without treating a family history or genetic test as a diagnosis.
Lowe has also spoken publicly about brain health awareness and barriers to timely diagnosis and care in Black and brown communities. The Being Patient interview raises those access concerns through her perspective, but it does not provide data measuring their scale or establish how often patients encounter the same barriers.
Products Worth Considering
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Garmin Venu 3 Fitness Smartwatch, 45 mm, Black
As an affiliate, we earn on qualifying purchases.
From Alzheimer’s Caregiver to Patient
Lowe’s mother was diagnosed with younger-onset Alzheimer’s at age 58, according to Being Patient. Lowe had been involved in her mother’s care and decisions for years before noticing changes in her own memory. The interview describes that history as important to how Lowe recognized and responded to her concerns.
Being Patient presented the conversation as part of its Journey to Diagnosis series. The publication disclosed that the series was sponsored by Eisai and said the sponsor had no role in selecting guests, shaping questions, or reviewing content before publication. The interview also touched on a recent concussion and access barriers, but the available source material does not provide enough detail to assess the concussion’s effects or its relationship, if any, to Lowe’s symptoms.
“I knew something wasn’t quite right, and I wanted answers.”
— Shon Lowe, speaking to Being Patient
What the Diagnosis Does Not Establish
The interview reports an MCI diagnosis but does not identify its cause, describe the full clinical assessment, or say whether Lowe has since received additional testing or a revised diagnosis. MCI is not presented in the source as equivalent to Alzheimer’s disease, and the article does not report that Lowe has been diagnosed with Alzheimer’s.
The source also does not provide details about the genetic test’s method, who interpreted the result, or how clinicians used it in evaluating Lowe. It does not clarify what role, if any, sleep problems, menopause, or the concussion mentioned in the interview played in her memory changes. Those details remain unreported; Lowe’s account alone cannot resolve them.
Further Evaluation and Care Details
Being Patient’s report does not specify Lowe’s next medical appointments, treatment plan, or any further diagnostic milestones. Those details will be needed to understand how her clinicians are monitoring her MCI and whether they identify a cause. The article offers no timeline for additional updates.
For now, the confirmed development in the source is Lowe’s reported November 2025 MCI diagnosis and her account of seeking evaluation after noticing changes. Any claims about progression, prognosis, or future care would go beyond the information provided.
Key Questions
What diagnosis did Shon Lowe receive?
Being Patient reports that Lowe received a diagnosis of mild cognitive impairment in November 2025. The report does not say she was diagnosed with Alzheimer’s disease.
What changes led Lowe to seek medical evaluation?
Lowe described forgetfulness, trouble recalling passwords, use of Post-it reminders, and occasionally putting items in the wrong place. She also said her youngest daughter encouraged her to get checked.
Did Lowe’s genetic test confirm Alzheimer’s?
No. Lowe told Being Patient that a test showed one copy of the APOE4 variant. The report does not describe that result as a diagnosis of Alzheimer’s or provide details about how clinicians interpreted it.
What role did her mother’s illness play in her diagnosis journey?
Lowe said caring for her mother, who was diagnosed with younger-onset Alzheimer’s at 58, made some of her own memory changes feel familiar and motivated her to pursue further evaluation.
What remains unknown about Lowe’s condition?
The report does not identify the cause of her MCI, provide details of her full clinical assessment, or say what follow-up care she will receive. It also does not establish whether menopause, sleep deprivation, or a concussion contributed to her symptoms.
Source: beingpatient.com
